# Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate

> **NCT02402283** · PHASE1 · COMPLETED · sponsor: **Verisfield UK Ltd. Greek Branch** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Metronidazole benzoate oral granules
- **DRUG:** Flagyl 400 mg Tablets

## Key facts

- **NCT ID:** NCT02402283
- **Lead sponsor:** Verisfield UK Ltd. Greek Branch
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02402283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02402283, "Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02402283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*